Teva Pharmaceuticals
TEVA
TEVA
440 hedge funds and large institutions have $5.55B invested in Teva Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 130 increasing their positions, 139 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
16% less capital invested
Capital invested by funds: $6.6B → $5.55B (-$1.05B)
17% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 47
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
440
Holding in Top 10
5
Calls
$268M
Puts
$310M
Top Buyers
| 1 | +$42.1M | |
| 2 | +$33.9M | |
| 3 | +$29.4M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$20.5M |
| 5 |
Citigroup
New York
|
+$16.2M |
Top Sellers
| 1 | -$63.9M | |
| 2 | -$50.6M | |
| 3 | -$48.8M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$39M |
| 5 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
-$32.4M |